Celldex Therapeutics, Inc.CLDXNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-191.90M
↓ 88% below average
Average (9y)
$-102.31M
Historical baseline
Range
High:$-45.64M
Low:$-191.90M
CAGR
+4.8%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-191.90M | -38.0% |
| 2023 | $-139.03M | -33.4% |
| 2022 | $-104.20M | -57.7% |
| 2021 | $-66.08M | -44.8% |
| 2020 | $-45.64M | +8.1% |
| 2019 | $-49.67M | +31.6% |
| 2018 | $-72.60M | +30.2% |
| 2017 | $-104.02M | +16.4% |
| 2016 | $-124.44M | +0.9% |
| 2015 | $-125.53M | - |